Yu Funahashi
Overview
Explore the profile of Yu Funahashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roy B, Verma A, Funahashi Y, Dwivedi Y
Clin Transl Med
. 2025 Mar;
15(3):e70135.
PMID: 40038891
Epigenetics plays a central role in neuropsychiatric disorders, contributing significantly to their complexity and manifestation. Major depressive disorder (MDD) and bipolar disorder (BD) have profound impact on mood, affect and...
2.
Iga J, Yoshino Y, Ozaki T, Tachibana A, Kumon H, Funahashi Y, et al.
J Alzheimers Dis Rep
. 2025 Mar;
8(1):1690-1703.
PMID: 40034360
Background: Abnormal immunity in the periphery has been reported in the pathogenesis of Alzheimer's disease (AD). Objective: In this study, blood transcriptome analyses of patients with AD, those with mild...
3.
Funahashi Y, Dwivedi Y
Epigenomics
. 2025 Jan;
17(4):247-262.
PMID: 39819344
Suicide continues to be a significant public health issue globally, claiming over 700,000 lives annually. It is, therefore, important to assess the suicide risk properly and provide intervention in a...
4.
Mori H, Yoshino Y, Okano M, Funahashi Y, Kumon H, Ochi S, et al.
Neuropsychopharmacol Rep
. 2024 Dec;
45(1):e12515.
PMID: 39715728
Aim: Recent studies have implicated autophagy in both weight regulation and depression. This study aimed to investigate the relationship between stress-induced weight loss and autophagy-related gene expression in a mouse...
5.
Mori H, Yoshino Y, Ueno M, Funahashi Y, Kumon H, Ozaki Y, et al.
PCN Rep
. 2024 Jun;
1(4):e65.
PMID: 38868661
Aim: This study aimed to investigate the expression levels and methylation status of () in the blood of Alzheimer's disease (AD) patients and age- and sex-matched healthy controls. Methods: Fifty...
6.
Kumon H, Yoshino Y, Funahashi Y, Ochi S, Iga J, Ueno S
IBRO Neurosci Rep
. 2023 Oct;
15:281-286.
PMID: 37860710
Antipsychotic treatment is vital for patients with schizophrenia even in the perinatal period, but the impact at the molecular biological level on offspring is unclear. The aim of the present...
7.
Mori H, Yoshino Y, Iga J, Ochi S, Funahashi Y, Yamazaki K, et al.
J Alzheimers Dis
. 2023 May;
94(1):177-188.
PMID: 37212113
Background: We explored the gene expression levels in the brain of 3xTg-AD model mice to elucidate the molecular pathological changes from the early to end stages of Alzheimer's disease (AD)....
8.
Kumon H, Yoshino Y, Ozaki T, Funahashi Y, Mori H, Ueno M, et al.
Brain Res Bull
. 2023 May;
199:110662.
PMID: 37150328
Background: The onset of schizophrenia is associated with both genetic and environmental risks during brain development. Environmental factors during pregnancy can represent risk factors for schizophrenia, and we have previously...
9.
Hosokawa R, Yoshino Y, Funahashi Y, Horiuchi F, Iga J, Ueno S
Brain Sci
. 2023 Jan;
13(1).
PMID: 36672009
Background: Autism spectrum disorder (ASD), is a neurodevelopmental disorder that is known to have a high degree of heritability. Diagnosis of ASD is difficult because of the high heterogeneity of...
10.
Funahashi Y, Yoshino Y, Iga J, Ueno S
World J Biol Psychiatry
. 2022 Jul;
24(4):303-313.
PMID: 35904423
Objectives: Recently, the expression changes of microRNAs (miRNAs) in the serum exosomes (EXO) of schizophrenia (SCZ) have been reported. The aim of this study was to investigate the global expression...